Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm

P. Pullicino, J. L P Thompson, J. P. Mohr, Ralph L Sacco, R. Freudenberger, B. Levin, S. Homma

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Despite many prospective randomized studies defining the benefits of anticoagulation in atrial fibrillation (AF), there have been no adequate studies in cardiomyopathy (CM) in sinus rhythm. Methods: We review the current knowledge of the risk of stroke in CM, left ventricular systolic dysfunction and heart failure as well as the indications for antithrombotic agents and compare this with AF. Results: The current knowledge of risk factors for stroke and indications for antithrombotic agents in CM is similar to that of AF prior to the treatment studies of the 1980s-1990s. Conclusion: Prospective randomized trial data are urgently needed to determine the role of antithrombotic drugs in CM.

Original languageEnglish
Pages (from-to)322-327
Number of pages6
JournalCerebrovascular Diseases
Volume26
Issue number3
DOIs
StatePublished - Sep 1 2008

Fingerprint

Cardiomyopathies
Heart Failure
Atrial Fibrillation
Fibrinolytic Agents
Stroke
Systolic Heart Failure
Left Ventricular Dysfunction
Prospective Studies
Pharmaceutical Preparations
Therapeutics

Keywords

  • Atrial fibrillation
  • Heart failure, anticoagulation
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pullicino, P., Thompson, J. L. P., Mohr, J. P., Sacco, R. L., Freudenberger, R., Levin, B., & Homma, S. (2008). Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. Cerebrovascular Diseases, 26(3), 322-327. https://doi.org/10.1159/000149581

Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. / Pullicino, P.; Thompson, J. L P; Mohr, J. P.; Sacco, Ralph L; Freudenberger, R.; Levin, B.; Homma, S.

In: Cerebrovascular Diseases, Vol. 26, No. 3, 01.09.2008, p. 322-327.

Research output: Contribution to journalArticle

Pullicino, P, Thompson, JLP, Mohr, JP, Sacco, RL, Freudenberger, R, Levin, B & Homma, S 2008, 'Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm', Cerebrovascular Diseases, vol. 26, no. 3, pp. 322-327. https://doi.org/10.1159/000149581
Pullicino, P. ; Thompson, J. L P ; Mohr, J. P. ; Sacco, Ralph L ; Freudenberger, R. ; Levin, B. ; Homma, S. / Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. In: Cerebrovascular Diseases. 2008 ; Vol. 26, No. 3. pp. 322-327.
@article{520ae8d1e01b4824a08ee7ac055206b0,
title = "Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm",
abstract = "Background: Despite many prospective randomized studies defining the benefits of anticoagulation in atrial fibrillation (AF), there have been no adequate studies in cardiomyopathy (CM) in sinus rhythm. Methods: We review the current knowledge of the risk of stroke in CM, left ventricular systolic dysfunction and heart failure as well as the indications for antithrombotic agents and compare this with AF. Results: The current knowledge of risk factors for stroke and indications for antithrombotic agents in CM is similar to that of AF prior to the treatment studies of the 1980s-1990s. Conclusion: Prospective randomized trial data are urgently needed to determine the role of antithrombotic drugs in CM.",
keywords = "Atrial fibrillation, Heart failure, anticoagulation, Stroke",
author = "P. Pullicino and Thompson, {J. L P} and Mohr, {J. P.} and Sacco, {Ralph L} and R. Freudenberger and B. Levin and S. Homma",
year = "2008",
month = "9",
day = "1",
doi = "10.1159/000149581",
language = "English",
volume = "26",
pages = "322--327",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm

AU - Pullicino, P.

AU - Thompson, J. L P

AU - Mohr, J. P.

AU - Sacco, Ralph L

AU - Freudenberger, R.

AU - Levin, B.

AU - Homma, S.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Background: Despite many prospective randomized studies defining the benefits of anticoagulation in atrial fibrillation (AF), there have been no adequate studies in cardiomyopathy (CM) in sinus rhythm. Methods: We review the current knowledge of the risk of stroke in CM, left ventricular systolic dysfunction and heart failure as well as the indications for antithrombotic agents and compare this with AF. Results: The current knowledge of risk factors for stroke and indications for antithrombotic agents in CM is similar to that of AF prior to the treatment studies of the 1980s-1990s. Conclusion: Prospective randomized trial data are urgently needed to determine the role of antithrombotic drugs in CM.

AB - Background: Despite many prospective randomized studies defining the benefits of anticoagulation in atrial fibrillation (AF), there have been no adequate studies in cardiomyopathy (CM) in sinus rhythm. Methods: We review the current knowledge of the risk of stroke in CM, left ventricular systolic dysfunction and heart failure as well as the indications for antithrombotic agents and compare this with AF. Results: The current knowledge of risk factors for stroke and indications for antithrombotic agents in CM is similar to that of AF prior to the treatment studies of the 1980s-1990s. Conclusion: Prospective randomized trial data are urgently needed to determine the role of antithrombotic drugs in CM.

KW - Atrial fibrillation

KW - Heart failure, anticoagulation

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=48049116412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48049116412&partnerID=8YFLogxK

U2 - 10.1159/000149581

DO - 10.1159/000149581

M3 - Article

VL - 26

SP - 322

EP - 327

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 3

ER -